Baker Bros. Advisors (GP) LLC, 10% Owner at Entrada Therapeutics, Inc. (TRDA), bought 345,684 shares at $7.95 ($2.6M) on 2025-11-12, disclosed to the SEC on 2025-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.21 | 2,296 | $17K | 0.6% |
| 2 | $7.21 | 25,364 | $183K | 7.0% |
| 3 | $7.21 | 25,364 | $183K | 7.0% |
| 4 | $7.22 | 267 | $2K | 0.1% |
| 5 | $7.22 | 2,947 | $21K | 0.8% |
| 6 | $7.39 | 11,701 |
| $86K |
| 3.3% |
| 7 | $7.39 | 1,059 | $8K | 0.3% |
| 8 | $7.39 | 11,701 | $86K | 3.3% |
| 9 | $7.54 | 30,879 | $233K | 8.9% |
| 10 | $7.54 | 2,795 | $21K | 0.8% |
| 11 | $7.54 | 30,879 | $233K | 8.9% |
| 12 | $7.73 | 7,321 | $57K | 2.2% |
| 13 | $7.73 | 80,881 | $625K | 23.8% |
| 14 | $7.73 | 80,881 | $625K | 23.8% |
| 15 | $7.73 | 7,321 | $57K | 2.2% |
| 16 | $7.95 | 11,494 | $91K | 3.5% |
| 17 | $7.95 | 1,040 | $8K | 0.3% |
| 18 | $7.95 | 11,494 | $91K | 3.5% |
| Total | $7.60 avg | 345,684 | $2.6M | 100% |
| Filing → |
| KOD | BUY | 2026-09-30 | $63.4M | — | Filing → |
| CELC | BUY | 2025-09-10 | $19.1M | — | Filing → |
| MDGL | BUY | 2025-08-20 | $73.7M | — | Filing → |